- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04617366
Dynamic Individualized rTMS Based on fNIRS
February 21, 2022 updated by: First Affiliated Hospital Xi'an Jiaotong University
Effect of Dynamic Individualized rTMS Based on fNIRS on Upper Limb Function of Stroke Patients
Stroke patients do not respond well to the traditional repetitive transcranial magnetic stimulation (rTMS) strategy based on the competitive model.
The studies found that the contralesional motion cortex has a compensatory effect on the realization of the motor function of the affected side-the compensatory model, and the degree of compensation will change as the function changes.
The optimal neural regulation strategies under different models are opposite, so it is important to accurately evaluate which of the two models plays the leading role.
And functional near-infrared spectroscopy (fNIRS) may accurately and quickly assess cortical function in order to determine the degree of participation of the contralesional motion cortex.
We propose that the dynamic individualized strategy which adjust the rTMS parameters promptly based on the results of fNIRS will be better than the traditional stimulation strategy.
This project will apply a blinded-assessment randomized controlled trial.
The test group selects either the high-frequency rTMS to the contralesional dorsal premotor cortex (PMd) or the low-frequency rTMS to the contralesional primary motor cortex (M1) based on the lateralization index of the PMd measured by fNIRS.
And the control group will always be given low-frequency rTMS to contralesional M1.
The difference in the improvement of upper limb function between the two groups of patients was compared.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ziwen Yuan, MD.
- Phone Number: +8617502991129
- Email: yuanziwen@xjtufh.edu.cn
Study Locations
-
-
Shaanxi
-
Xi'an, Shaanxi, China, 710000
- Recruiting
- The First Affiliated Hospital of Xi'an Jiaotong University
-
Contact:
- Ziwen Yuan, MD.
- Phone Number: +8617502991129
- Email: yuanziwen@xjtufh.edu.cn
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 79 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Aged 40-79 years;
- Patients with first-onset subcortical infarcts within1 to 3 weeks after onset;
- TMS on the lesion side can induce motor evoked potential(MEP) of the abductor pollicis brevis muscle of the affected hand;
- Consciousness, sitting balance level 1 or above, can cooperate with assessment and treatment;
- The patient or its authorized agent signs the informed consent form.
Exclusion Criteria:
- Previous seizures;
- Suffered from mental illness such as depression, anxiety, mania, and schizophrenia before the stroke onset;
- Patients with metal on the head, cochlear implants, intracranial infections, etc. who are not suitable for rTMS.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Individualized rTMS strategy
The individualized strategy will adjust the rTMS parameters promptly based on the results of fNIRS.
This arm selects either the high-frequency rTMS to the contralesional dorsal premotor cortex (PMd) or the low-frequency rTMS to the contralesional primary motor cortex (M1) based on the lateralization index of the PMd measured by fNIRS.
|
It will adjust the rTMS parameters based on the results of fNIRS.
|
|
Active Comparator: Traditional rTMS strategy
The control group will always be given low-frequency rTMS to contralesional M1.
|
The patients will always be given low-frequency rTMS to contralesional M1.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fugl-Meyer motor function score of upper limb
Time Frame: 3 months
|
The score range is 0-66 points, the higher the score, the better the motor function of upper limb.
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Barthel index
Time Frame: 3 months
|
The score range is 0-100 points, the higher the score, the better the activities of daily living.
|
3 months
|
|
Lateralization index (LI)
Time Frame: 3 months
|
The LI score measured by fNIRS ranges from -1 to 1, with 1 indicating purely ipsilesional and -1 indicating purely contralesional activation.
|
3 months
|
|
Brain functional connection network
Time Frame: 3 months
|
Using fNIRS to analyze the functional connection network between the motor areas of the bilateral cerebral hemispheres.
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 5, 2020
Primary Completion (Anticipated)
December 31, 2023
Study Completion (Anticipated)
March 31, 2024
Study Registration Dates
First Submitted
October 28, 2020
First Submitted That Met QC Criteria
November 1, 2020
First Posted (Actual)
November 5, 2020
Study Record Updates
Last Update Posted (Actual)
February 23, 2022
Last Update Submitted That Met QC Criteria
February 21, 2022
Last Verified
February 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- XJUFH-R-002
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
University Hospital HeidelbergCompletedAcute Ischemic Stroke | Acute Ischemic Stroke AIS | Acute Ischemic Stroke PatientsGermany
Clinical Trials on Individualized rTMS strategy
-
Stanford UniversityNational Institute of Mental Health (NIMH)CompletedMajor Depressive DisorderUnited States
-
National University Hospital, SingaporeRecruitingOut-Of-Hospital Cardiac Arrest (OHCA)Singapore
-
First Affiliated Hospital Xi'an Jiaotong UniversityRecruiting
-
Linda DouwRecruitingGlioma | Cognitive ImpairmentNetherlands
-
Ulrikka NygaardUniversity of Copenhagen; Innovation Fund DenmarkCompletedAntibiotic Side Effect | Early-Onset Neonatal SepsisDenmark
-
Seoul National University HospitalRecruitingMajor Non-cardiac SurgeryKorea, Republic of
-
Massachusetts General HospitalNational Institute of Allergy and Infectious Diseases (NIAID); Bill and Melinda... and other collaboratorsRecruitingHIV Infections | AIDS | Virologic FailureSouth Africa, Uganda
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Radboud University Medical Center; University of Roma La Sapienza; University... and other collaboratorsCompletedPostoperative Respiratory ComplicationNetherlands, Germany, Italy
-
University Hospital, Strasbourg, FranceActive, not recruitingSchizophreniform Catatonia | Treatment ResistantFrance
-
Bakirkoy Dr. Sadi Konuk Research and Training HospitalCompletedPostoperative Pulmonary Complications | Recruitment Maneuver | Individualized PEEP | Total HysterectomyTurkey (Türkiye)